Please assess the completion status of the following clinical trial:

Trial Title: Effect of Antenatal Corticosteroids on Neonatal Morbidity.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation and a probability of delivery in the late preterm period irrespective of diagnosis who give consent.~* Pregnant women at 34 weeks 0 days to 36 weeks 6 days of gestation scheduled for elective/emergency delivery in the late preterm period irrespective of indication and route of delivery who give consent.~Exclusion Criteria:~* Evidence of Chrioamnionitis.~* Evidence of foetal distress.~* History of use of antenatal corticosteroids in index pregnancy.~* Women who do not give consent.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Dexamethasone sodium phosphate injection (Type: EXPERIMENTAL): Intervention: Drug: Dexamethasone sodium phosphate injection Two doses Intramuscular Dexamethasone sodium phosphate 12mg given12 hours apart. (produced by Taizhou Overseas International Ltd. 126-128 Qingnian Road Jiaojiang, Taizhou, Zhejiang, China)
- Betamethasone sodium phosphate injection (Type: EXPERIMENTAL): Intervention: Drug: Betamethasone sodium phosphate injection Two doses of intramuscular betamethasone sodium phosphate 12mg given 12 hours apart. (obtained from Twinbrook pkwy, Rockville, MD Singapore. CAT No 1068004, Lot: R004e0)
- Water for injection (Type: PLACEBO_COMPARATOR): Intervention. Drug: Water for injection. Two doses of intramuscular water for injection given 12 hours apart.

Based on this trial design, predict the completion outcome and termination type (if applicable).